Paul G. Sleph

4.2k total citations
69 papers, 3.1k citations indexed

About

Paul G. Sleph is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Paul G. Sleph has authored 69 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pathology and Forensic Medicine, 24 papers in Cardiology and Cardiovascular Medicine and 23 papers in Molecular Biology. Recurrent topics in Paul G. Sleph's work include Cardiac Ischemia and Reperfusion (40 papers), Cardiac electrophysiology and arrhythmias (19 papers) and Cardiac Arrest and Resuscitation (15 papers). Paul G. Sleph is often cited by papers focused on Cardiac Ischemia and Reperfusion (40 papers), Cardiac electrophysiology and arrhythmias (19 papers) and Cardiac Arrest and Resuscitation (15 papers). Paul G. Sleph collaborates with scholars based in United States, Germany and Sweden. Paul G. Sleph's co-authors include Steven Dzwonczyk, Gary J. Grover, G. J. Grover, Charles S. Parham, Diane E. Normandin, John R. McCullough, Mary Lee Conder, Blake C. Beehler, Karnail S. Atwal and Raymond B. Darbenzio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Circulation Research.

In The Last Decade

Paul G. Sleph

69 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul G. Sleph United States	32	1.5k	1.0k	842	761	462	69	3.1k
Gary J. Grover United States	36	1.9k 1.3×	1.7k 1.7×	924 1.1×	746 1.0×	480 1.0×	104	4.6k
E K Lai United States	14	1.0k 0.7×	830 0.8×	385 0.5×	495 0.7×	261 0.6×	16	2.8k
Grant R. Budas United States	29	1.2k 0.8×	1.5k 1.5×	330 0.4×	776 1.0×	74 0.2×	49	3.0k
Gerald A. Cordis United States	28	1.1k 0.7×	929 0.9×	314 0.4×	429 0.6×	107 0.2×	54	2.5k
Xin L. United States	27	812 0.5×	1.3k 1.3×	238 0.3×	1.1k 1.4×	54 0.1×	44	3.4k
A Manning United Kingdom	23	991 0.7×	622 0.6×	341 0.4×	1.1k 1.4×	124 0.3×	62	2.2k
Wei Dong Gao United States	27	659 0.4×	1.2k 1.2×	228 0.3×	1.6k 2.0×	77 0.2×	88	2.9k
Mohamed O. Jeroudi United States	16	1.3k 0.9×	429 0.4×	575 0.7×	956 1.3×	124 0.3×	18	2.5k
Peter Proks United Kingdom	39	1.3k 0.9×	2.5k 2.5×	219 0.3×	542 0.7×	45 0.1×	96	5.0k
Samantha J. Clarke United Kingdom	10	1.0k 0.7×	1.6k 1.5×	361 0.4×	231 0.3×	53 0.1×	10	2.4k

Countries citing papers authored by Paul G. Sleph

Since Specialization

Citations

This map shows the geographic impact of Paul G. Sleph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul G. Sleph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul G. Sleph more than expected).

Fields of papers citing papers by Paul G. Sleph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul G. Sleph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul G. Sleph. The network helps show where Paul G. Sleph may publish in the future.

Co-authorship network of co-authors of Paul G. Sleph

This figure shows the co-authorship network connecting the top 25 collaborators of Paul G. Sleph. A scholar is included among the top collaborators of Paul G. Sleph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul G. Sleph. Paul G. Sleph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, James J., Haixia Wang, Jun Li, et al.. (2008). Tetrazole based amides as growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 18(8). 2536–2539. 9 indexed citations

Li, Jun, Stephanie Chen, Brian J. Murphy, et al.. (2008). (d)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: Synthesis and incorporation into the growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 18(14). 4072–4074. 11 indexed citations

Hernández, Andrés S., Mujing Yan, Ramakrishna Seethala, et al.. (2008). Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 18(6). 2067–2072. 3 indexed citations

Devasthale, Pratik, Sean Chen, Yoon Jeon, et al.. (2007). Discovery of tertiary aminoacids as dual PPARα/γ agonists-I. Bioorganic & Medicinal Chemistry Letters. 17(8). 2312–2316. 7 indexed citations

Ostrowski, Jacek, John A. Lupisella, Blake C. Beehler, et al.. (2006). Pharmacological and X-Ray Structural Characterization of a Novel Selective Androgen Receptor Modulator: Potent Hyperanabolic Stimulation of Skeletal Muscle with Hypostimulation of Prostate in Rats. Endocrinology. 148(1). 4–12. 99 indexed citations

Grover, Gary J., Paul G. Sleph, Blake C. Beehler, et al.. (2004). Effects of the Thyroid Hormone Receptor Agonist GC-1 on Metabolic Rate and Cholesterol in Rats and Primates: Selective Actions Relative to 3,5,3′-Triiodo-l-Thyronine. Endocrinology. 145(4). 1656–1661. 139 indexed citations

DʼAlonzo, Albert J., Gary J. Grover, Raymond B. Darbenzio, et al.. (1995). In vitro effects of capsaicin: antiarrhythmic and antiischemic activity. European Journal of Pharmacology. 272(2-3). 269–278. 41 indexed citations

Grover, Gary J. & Paul G. Sleph. (1995). Protective Effect of KATP Openers in Ischemic Rat Hearts Treated with a Potassium Cardioplegic Solution. Journal of Cardiovascular Pharmacology. 26(5). 698–706. 18 indexed citations

Atwal, Karnail S., Gary J. Grover, Syed Z. Ahmed, et al.. (1995). Cardioselective Anti-Ischemic ATP-Sensitive Potassium Channel Openers. 3. Structure-Activity Studies on Benzopyranyl Cyanoguanidines; Modification of the Cyanoguanidine Portion. Journal of Medicinal Chemistry. 38(17). 3236–3245. 17 indexed citations

10.

Grover, G. J., et al.. (1994). The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.. Journal of Pharmacology and Experimental Therapeutics. 269(2). 536–540. 20 indexed citations

11.

Grover, G. J. & Paul G. Sleph. (1994). The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activation.. Journal of Pharmacology and Experimental Therapeutics. 268(1). 90–96. 9 indexed citations

12.

D'Alonzo, A J, et al.. (1994). Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia. Cardiovascular Research. 28(6). 881–887. 36 indexed citations

13.

Sargent, Carol A., Paul G. Sleph, Steven Dzwonczyk, et al.. (1993). Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 609–618. 24 indexed citations

14.

Grover, G. J., Paul G. Sleph, Steven Dzwonczyk, & John R. McCullough. (1993). Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.. Journal of Pharmacology and Experimental Therapeutics. 267(1). 102–107. 6 indexed citations

15.

Sargent, Carol A., Paul G. Sleph, Steven Dzwonczyk, Mark A. Smith, & Gary J. Grover. (1992). Effect of Calmodulin and Protein Kinase C Inhibitors on Globally Ischemic Rat Hearts. Journal of Cardiovascular Pharmacology. 20(2). 251–260. 11 indexed citations

16.

Grover, G. J., Paul G. Sleph, & Steven Dzwonczyk. (1992). Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors.. Circulation. 86(4). 1310–1316. 206 indexed citations

17.

Grover, Gary J., Steven Dzwonczyk, Charles S. Parham, & Paul G. Sleph. (1990). The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovascular Drugs and Therapy. 4(2). 465–474. 106 indexed citations

18.

Grover, Gary J., Steven Dzwonczyk, & Paul G. Sleph. (1990). Ruthenium Red Improves Postischemic Contractile Function in Isolated Rat Hearts. Journal of Cardiovascular Pharmacology. 16(5). 783–789. 40 indexed citations

19.

Grover, G. J., et al.. (1989). Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.. Journal of Pharmacology and Experimental Therapeutics. 251(1). 98–104. 150 indexed citations

20.

Grover, Gary J., Paul G. Sleph, & Charles S. Parham. (1988). The Role of Thromboxane A2 in Reperfusion Injury. Experimental Biology and Medicine. 188(4). 504–508. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact